Hope appears to be rising for a solution to coronavirus after some researchers at the Migal Galilee Research Institute (MIGAL) in Israel claimed to havedeveloped a vaccine against avian coronavirus infectious bronchitis virus (IBV),a precursorof a human vaccine against coronavirus (COVID-19).

The vaccine, according to them, has been proven in pre-clinical trials.

A Nigerian professor of virology, Maduike Ezeibe, has also said he has a cure for the virus and lassa fever.

Ezeibe is the Dean, College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike (MOUAU).

The Israeli researchers said they have achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against coronavirus.

Havingmade therequired genetic adjustments to adapt the vaccine to COVID-19, the human strain of coronavirus, what is next for the Israelis is to achieve the safety approvals preparatory to the of production of thevaccine to neutralizecoronavirus .

They plan to produce the vaccine overthe next 8-10 weeks andachieve safety approval in three months.

Nigerian don ‘discovers cure for coronavirus, lassa fever’

Professor Ezeibe said his therapy has the potency to cure coronavirus and lassa fever.

The professor of Virology who gave the chemical equation of the therapy as (AI4(SiO4)3+3Mg2SiO4-2AI2Mg3(SiO4)3) said “it’s a mechanism for curing Covid -19 and Lassa fever”.

On how the therapy works, Professor Ezeibe said: “that electrostatic attraction would make electrically charged medicines mop pathogens which have opposite chargesis a known scientific fact and that viruses and abnormal (infected /tumor) cells are electrically charged is now known.

“Covid-19 virus and Lassa fever virus (DNA viruses) are negatively charged. Small sizes of viruses enable them infect cells, inaccessible to big molecules. So, existing antiviral medicines need immunity to complement their effects but some viruses cause immune deficiency.

“As a silicate, AMS also normalises immunity and as a stabilizing agent it enhances efficacy of antimicrobials to achieve effective treatment secondary infections.

“Effective treatment of secondary infections would cure any viral /abnormal cell diseases including Covid -19 and Lassa fever.”

He expressed confidence that the therapy which had already proved reliable in the treatment of HIV/AIDS would make coronavirus a thing of the past.

Asked about the cost of treatment, Professor Ezeibe said “cost is not an issue for now”, maintaining that what is of moment is to bring cure to the thousands of patients already infested with the virus. (The Nation)